- Home
- XPOF vs DRUG Comparison
XPOF vs DRUG Comparison
Compare XPOF & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- DRUG
- Stock Information
- Founded
- XPOF 2017
- DRUG 2019
- Country
- XPOF United States
- DRUG United States
- Employees
- XPOF N/A
- DRUG N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- DRUG Pharmaceuticals and Biotechnology
- Sector
- XPOF Consumer Discretionary
- DRUG Health Care
- Exchange
- XPOF Nasdaq
- DRUG Nasdaq
- Market Cap
- XPOF 302.9M
- DRUG 345.6M
- IPO Year
- XPOF 2021
- DRUG N/A
- Fundamental
- Price
- XPOF $8.14
- DRUG $44.68
- Analyst Decision
- XPOF Buy
- DRUG Strong Buy
- Analyst Count
- XPOF 7
- DRUG 9
- Target Price
- XPOF $12.93
- DRUG $81.67
- AVG Volume (30 Days)
- XPOF 610.6K
- DRUG 69.3K
- Earning Date
- XPOF 11-06-2025
- DRUG 08-11-2025
- Dividend Yield
- XPOF N/A
- DRUG N/A
- EPS Growth
- XPOF N/A
- DRUG N/A
- EPS
- XPOF N/A
- DRUG N/A
- Revenue
- XPOF $316,841,000.00
- DRUG N/A
- Revenue This Year
- XPOF N/A
- DRUG N/A
- Revenue Next Year
- XPOF $3.45
- DRUG N/A
- P/E Ratio
- XPOF N/A
- DRUG N/A
- Revenue Growth
- XPOF N/A
- DRUG N/A
- 52 Week Low
- XPOF $6.64
- DRUG $0.94
- 52 Week High
- XPOF $18.87
- DRUG $79.02
- Technical
- Relative Strength Index (RSI)
- XPOF 41.56
- DRUG 55.32
- Support Level
- XPOF $8.10
- DRUG $39.70
- Resistance Level
- XPOF $9.04
- DRUG $49.38
- Average True Range (ATR)
- XPOF 0.41
- DRUG 3.13
- MACD
- XPOF 0.02
- DRUG -0.06
- Stochastic Oscillator
- XPOF 10.00
- DRUG 58.14
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.